thalidomide has been researched along with Congestive Ophthalmopathy in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, C | 1 |
| Zhang, X | 1 |
| Ma, L | 1 |
| Peng, F | 1 |
| Huang, J | 1 |
| Han, H | 1 |
| Tanda, ML | 1 |
| Piantanida, E | 1 |
| Bartalena, L | 1 |
2 other studies available for thalidomide and Congestive Ophthalmopathy
| Article | Year |
|---|---|
Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.
Topics: 3T3-L1 Cells; Adipocytes, White; Adipogenesis; Animals; Cells, Cultured; Down-Regulation; Fatty Acid | 2012 |
Treating Graves' orbitopathy: where are we?
Topics: Adipocytes, White; Adipogenesis; Animals; Antithyroid Agents; Down-Regulation; Female; Graves Ophtha | 2012 |